BCM
GRTS

Bridgeway Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bridgeway Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-119,400
Closed -$69.2K – 1326
2024
Q3 		$69.2K Sell
119,400
-20,000
-14% -$11.2K ﹤0.01% 1191
2024
Q2 		$86.1K Sell
139,400
-124,500
-47% -$105K ﹤0.01% 1171
2024
Q1 		$678K Buy
263,900
+70,000
+36% +$171K 0.01% 838
2023
Q4 		$396K Hold
193,900
– – 0.01% 997
2023
Q3 		$334K Hold
193,900
– – 0.01% 991
2023
Q2 		$378K Buy
193,900
+11,000
+6% +$25.8K 0.01% 983
2023
Q1 		$508K Sell
182,900
-23,100
-11% -$66K 0.01% 883
2022
Q4 		$711K Buy
206,000
+80,000
+63% +$228K 0.02% 807
2022
Q3 		$324K Buy
126,000
+102,900
+445% +$328K 0.01% 1015
2022
Q2 		$56K Hold
23,100
– – ﹤0.01% 1276
2022
Q1 		$95K Sell
23,100
-55,000
-70% -$291K ﹤0.01% 1262
2021
Q4 		$1M Sell
78,100
-71,900
-48% -$796K 0.02% 789
2021
Q3 		$1.62M Hold
150,000
– – 0.03% 699
2021
Q2 		$1.37M Sell
150,000
-25,000
-14% -$231K 0.02% 751
2021
Q1 		$1.65M Hold
175,000
– – 0.03% 692
2020
Q4 		$690K Buy
+175,000
New +$529K 0.01% 843

Other funds holding GRTS

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Bridgeway Capital Management's GRTS Position: Q4 2024 in Review

Bridgeway Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 119,400 shares — an estimated $69.2K sold.

Bridgeway Capital Management first reported a position in GRTS in Q4 2020 and held it in 16 quarters. The position peaked at $1.65M in Q1 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Bridgeway Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 119,400 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $69.2K.
  • Bridgeway Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 16 quarters.
  • Bridgeway Capital Management's Gritstone bio, Inc. Common Stock position peaked at $1.65M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.